Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medicure Inc V.MPH

Alternate Symbol(s):  MCUJF

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.


TSXV:MPH - Post by User

Bullboard Posts
Post by clameton Oct 17, 2014 8:16pm
232 Views
Post# 23039724

MEDICURE he's a strong buy / analist recomendation

MEDICURE he's a strong buy / analist recomendation


Consensus Rating Average
Consensus Rating for MPH is STRONG BUY
Since many brokers have different rating systems, we maintain a standard system with an assigned numeric value from 1 to 5. Ratings are a translation of brokers' recommendations to the recommendation scale, which ranges from a rating of 1 (a strong buy) to a rating of 5 (a strong sell).
Rating Scale
 
Strong Buy 1.0 - 1.5
 
Moderate Buy 1.6 - 2.5
 
Hold 2.6 - 3.5
 
Moderate Sell 3.6 - 4.5
 
Strong Sell 4.6 - 5.0
Consensus Rating Details
Current Average Recommendation 1.00
Previous Average Recommendation 0.00
Change in Average Recommendation 1.00
Number of Analysts Reporting 1
Strong Buy
1.0
Current: 1.00
 
 
Previous: 0.00
Change: 1.00
Strong Sell
5.0
 
Consensus Rating Industry Comparison
Industry: MED-DRUGS
Number of companies in industry with recommendations 148
Rank Recommendation relative to companies in its industry 50
Ranked 50 in Industry
 
 
1148MED-DRUGS
 
Analyst Recommendations
Analysts recommending Strong Buy 1
Analysts recommending Moderate Buy 0
Analysts recommending Hold 0
Analysts recommending Moderate Sell 0
Analysts recommending Strong Sell 0
Vertical Bar Chart
 
Recommendations History
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.00 0.00 0.00 0.00

Bullboard Posts